跳至主要内容
临床试验/JPRN-jRCTs032180314
JPRN-jRCTs032180314已完成未知

The theRapeutic effects of peroneal nerve functionAl electrical stimuLation for Lower extremitY in patients with sub-acute post-stroke hemiplegia (RALLY) A randomized controlled study - RALLY study

Matsumoto Shuji0 个研究点目标入组 203 人开始时间: 2019年3月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
203

研究概览

简要总结

The findings of the current study demonstrated the feasibility of applying WA for dropped foot during the convalescent phase of recovery after stroke.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 85age old(—)
性别
All

入选标准

  • 1) Patients who agree to participate in this study and provide their informed consent
  • 2) Patients from 20 to 85 years old at the time of consent
  • 3) Patients of convalescent stoke (within 6 months of onset)
  • 4) Patients with a first episode of stroke, which type limited intracranial hemorrhage or ischemic stroke (excluding subarachnoid hemorrhage)
  • 5) Patients inpatients for the rehabilitation therapy
  • 6) Patients diagnosed 3 or 4 on Functional Ambulation Classification (FAC)
  • 7) Patients stable general condition (blood pressure, pulse, blood glucose level etc.)
  • 8) Patients with drop foot in walking

排除标准

  • 1) Patients due to severe heart disease
  • 2) Patients with previous gait disability, such as neurological disease
  • 3) Patients with previous orthopedic disease, such as knee osteoarthritis
  • 4) Patients with severe hepatic or renal dysfunction
  • 5) Patients with severe sensory disturbance or severe ataxia or severe higher brain dysfunction
  • 6) Patients correspond to contraindicated for the electrical stimulation (e.g. patients with a medical implant or implantable medical electrical equipment such as a cardiac pacemaker)
  • 7) Patients with severe skin disease
  • 8) Patients with any dose adjustment of antispasticity drugs (tizanidine hydrochloride, eperisone hydrochloride, baclofen, etc.) within 1month
  • 9) Patients whose impairment severities changed during the study period
  • 10) Patients taking the botulinum toxin formulation injection or the nerve block injection with phenol within 6months
  • 11) Patients with any lower limb treatment using FES or the robot suit within 1month
  • 12) Patients diagnosed not to use during the WA trial operation period
  • 13) Patients who do not complete the WA trial operation for 7 days
  • 14) Patients joining any other clinical trials or studies with intervention

研究者

发起方
Matsumoto Shuji

相似试验